CAR T-cell Therapy: Remote Patient Monitoring CANCER BUZZ

While remote monitoring platforms have been used effectively throughout the COVID-19 pandemic to reduce the burden on patients and healthcare facilities around the country, Vanderbilt Ingram Cancer Center in Nashville, Tenn., has been using the technology in a different capacity—with its patients on CAR T-cell therapy. To avoid a lengthy inpatient stay, these patients are seen daily in Vanderbilt’s outpatient clinic and then monitored virtually 24/7 at home or—for those who must travel to receive treatment—at their temporary lodging. The remote technology alerts cancer program staff of any significant changes in clinical status that would initiate a hospital admission. 
Guest:
Brittney M. Baer, BSN, RN
Patient Care Coordinator
Vanderbilt University Medical Center 
Resources:
Bringing CAR T-cell Therapy to Community Oncology Overview
CAR T-cell Practice Profile – Fox Chase Cancer Center
CAR T-cell Practice Profile – Billings Clinic Cancer Center
Gap Analysis: Bringing CAR T-cell Therapy to Community Oncology 
IO Insight: Telemedicine and Cancer Care